Literature DB >> 28990294

Genetic and molecular risk factors within the newly identified primate-specific exon of the SAP97/DLG1 gene in the 3q29 schizophrenia-associated locus.

Akihito Uezato1, Naoki Yamamoto1,2, Daisuke Jitoku1, Emiko Haramo1, Eri Hiraaki1, Yoshimi Iwayama3, Tomoko Toyota3, Masakazu Umino1, Asami Umino1, Yasuhide Iwata4, Katsuaki Suzuki4, Mitsuru Kikuchi5, Tasuku Hashimoto6, Nobuhisa Kanahara6, Akeo Kurumaji1, Takeo Yoshikawa3, Toru Nishikawa1.   

Abstract

The synapse-associated protein 97/discs, large homolog 1 of Drosophila (DLG1) gene encodes synaptic scaffold PDZ proteins interacting with ionotropic glutamate receptors including the N-methyl-D-aspartate type glutamate receptor (NMDAR) that is presumed to be hypoactive in brains of patients with schizophrenia. The DLG1 gene resides in the chromosomal position 3q29, the microdeletion of which confers a 40-fold increase in the risk for schizophrenia. In the present study, we performed genetic association analyses for DLG1 gene using a Japanese cohort with 1808 schizophrenia patients and 2170 controls. We detected an association which remained significant after multiple comparison testing between schizophrenia and the single nucleotide polymorphism (SNP) rs3915512 that is located within the newly identified primate-specific exon (exon 3b) of the DLG1 gene and constitutes the exonic splicing enhancer sequence. When stratified by onset age, although it did not survive multiple comparisons, the association was observed in non-early onset schizophrenia, whose onset-age selectivity is consistent with our recent postmortem study demonstrating a decrease in the expression of the DLG1 variant in early-onset schizophrenia. Although the present study did not demonstrate the previously reported association of the SNP rs9843659 by itself, a meta-analysis revealed a significant association between DLG1 gene and schizophrenia. These findings provide a valuable clue for molecular mechanisms on how genetic variations in the primate-specific exon of the gene in the schizophrenia-associated 3q29 locus affect its regulation in the glutamate system and lead to the disease onset around a specific stage of brain development.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  exonic splicing enhancer; expression; genetic association; glutamate; onset

Mesh:

Substances:

Year:  2017        PMID: 28990294     DOI: 10.1002/ajmg.b.32595

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  6 in total

1.  Differential genetic associations and expression of PAPST1/SLC35B2 in bipolar disorder and schizophrenia.

Authors:  Akihito Uezato; Daisuke Jitoku; Dai Shimazu; Naoki Yamamoto; Akeo Kurumaji; Yoshimi Iwayama; Tomoko Toyota; Takeo Yoshikawa; Vahram Haroutunian; Eduard Bentea; Jarek Meller; Courtney R Sullivan; James H Meador-Woodruff; Robert E McCullumsmith; Toru Nishikawa
Journal:  J Neural Transm (Vienna)       Date:  2022-05-02       Impact factor: 3.850

2.  Convergent and distributed effects of the 3q29 deletion on the human neural transcriptome.

Authors:  Esra Sefik; Ryan H Purcell; Elaine F Walker; Gary J Bassell; Jennifer G Mulle
Journal:  Transl Psychiatry       Date:  2021-06-15       Impact factor: 6.222

3.  SAP97 regulates behavior and expression of schizophrenia risk enriched gene sets in mouse hippocampus.

Authors:  Preetika Gupta; Ogul E Uner; Soumyashant Nayak; Gregory R Grant; Robert G Kalb
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

4.  Association of the Synapse-Associated Protein 97 (SAP97) Gene Polymorphism With Neurocognitive Function in Schizophrenic Patients.

Authors:  Xusan Xu; Chunmei Liang; Dong Lv; Jingwen Yin; Xudong Luo; Jiawu Fu; Haifeng Yan; Xia Zhou; Zhun Dai; Dongjian Zhu; Susu Xiong; Zhixiong Lin; Juda Lin; Bin Zhao; You Li; Yajun Wang; Guoda Ma; Keshen Li
Journal:  Front Psychiatry       Date:  2018-09-26       Impact factor: 4.157

5.  Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series.

Authors:  Eva Albertsen Malt; Katalin Juhasz; Anna Frengen; Teresia Wangensteen; Nina Merete Emilsen; Borre Hansen; Oleg Agafonov; Hilde Loge Nilsen
Journal:  Mol Genet Genomic Med       Date:  2019-07-25       Impact factor: 2.183

6.  Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson's and Alzheimer's Disease Patients.

Authors:  Anna Di Maio; Arianna De Rosa; Silvia Pelucchi; Martina Garofalo; Benedetta Marciano; Tommaso Nuzzo; Fabrizio Gardoni; Andrea M Isidori; Monica Di Luca; Francesco Errico; Andrea De Bartolomeis; Elena Marcello; Alessandro Usiello
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.